IL6 and periodontitis: Studies by our research group evaluating the effect of JAK inhibition on alveolar bone resorption in a model of periodontitis in rats also observed a protective effect of the inhibitor on bone loss and a reduction of IL-6 levels in periodontal tissues, also suggesting the involvement of IL-6 signaling in the effects of JAK on inflammatory bone resorption [26].